NCT03176810 (COCOA) is a NA clinical trial of OCT in Coronary Disease, sponsored by Takashi Kubo, MD.

Who is sponsoring NCT03176810?

NCT03176810 is sponsored by Takashi Kubo, MD.

What drugs are being tested in NCT03176810?

Interventions in NCT03176810: OCT, Angiography.

What condition does NCT03176810 study?

NCT03176810 studies Coronary Disease.

Is NCT03176810 still recruiting?

NCT03176810 is currently status unknown. Last updated 8 October 2019.

Last reviewed 2019-10-08 · How we verify

NCT03176810: COCOA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison Between Optimal Coherence Tomography Guidance and Angiography Guidance in Percutaneous Coronary Intervention

Status unknown NA Last updated 8 October 2019

What this trial tests

NA trial testing OCT in Coronary Disease in 550 participants. Status unknown.

Timeline

1 April 2017

Primary endpoint
30 June 2020

30 June 2021

Quick facts

Lead sponsor	Takashi Kubo, MD
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	550
Start date	1 April 2017
Primary completion	30 June 2020
Estimated completion	30 June 2021
Sites	1 location across Japan

Drugs / interventions tested

OCT
Angiography

Conditions studied

Coronary Disease — all drugs for Coronary Disease →

Sponsor

Takashi Kubo, MD

Who can join

Adults 20 to 100, any sex, with Coronary Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The present study aims to demonstrate the superiority of optical coherence tomography (OCT)-guided percutaneous coronary intervention (PCI) compared with Angiography-guided PCI.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of OCT

Trials testing the same drug.

NCT07149740 — Data Gathering for A10900 · recruiting
NCT05135312 — Etanercept Therapy for Nails Psoriasis Monitoring With Noninvasive Imaging · Phase 4 · unknown
NCT06442176 — Choroid In Coronary Artery Disease · completed
NCT04356027 — FUnctional diagnoSIs of corONary Stenosis (FUSION) · completed
NCT04610645 — Optical Coherence Tomography in Patients With Radiotherapy for Head and Neck Cancer · completed

Other recruiting trials for Coronary Disease

Currently open trials in the same condition.

NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT06736899 — Trial of Orbital Atherectomy Versus Standard Strategy in Calcified Bifurcation Lesions · NA · recruiting
NCT06890208 — Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave · recruiting
NCT07094737 — The Italian Alliance for Cardiovascular Rehabilitation and Prevention (ITACARE-P) Registry: An Observational Study on Ca · recruiting
NCT06701968 — Effects of a Healthy Nordic Diet on Atherosclerosis in Patients with Coronary Heart Disease · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03176810 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Takashi Kubo, MD
Last refreshed: 8 October 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03176810.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing